Obstetrics and GynecologyObstetrics and GynecologyАкушерство и гинекология0300-90922412-5679Bionika Media246603ArticlesСтатьиReview ArticleUSE OF VOLUME-FORMING DRUGS TO TREAT FEMALE STRESS URINARY INCONTINENCEПРИМЕНЕНИЕ ОБЪЕМООБРАЗУЮЩИХ СРЕДСТВ ДЛЯ ЛЕЧЕНИЯ СТРЕССОВОГО НЕДЕРЖАНИЯ МОЧИ У ЖЕНЩИНAPOLIKHINAI. AАПОЛИХИНАИнна Анатольевна

д-р мед. наук, проф. каф. акушерства, гинекологии, перинатологии и репродуктологии ФППО врачей

apolikhina@inbox.ruSAIDOVAA. SСАИДОВАА. СMAKHMEDZHANOVAF. NМАХМЕДЖАНОВАФ. НI. M. Sechenov First Moscow State Medical University1 ГОУ ВПО Первый МГМУ им. И.М. СеченоваAcademician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of RussiaФГУ Научный центр акушерства гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития России150720117-1NO7 (2011)№7-1 (2011)212417022023Copyright ©; 2011, Bionika MediaCopyright ©; 2011, ООО «Бионика Медиа»2011Bionika MediaООО «Бионика Медиа»https://journals.eco-vector.com/0300-9092/article/view/246603

The review gives the data available in the literature on experience with peri- and transurethral injections of current volume-forming agents used in stress urinary incontinence as a certain alternative if surgical treatment is impossible. Although the efficiency of surgical treatment is statistically significantly higher, the use of volume-forming agents is associated with the lower frequency of complications. The efficacy of peri- and transurethral injections remains about a year. Reinjections are necessary to maintain the effect of urinary continence.

В обзоре приведены данные литературы об опыте применения пери- и трансуретральных инъекций различных современных объемообразующих средств при стрессовом недержании мочи как определенной альтернативы при невозможности проведения хирургического лечения. Хотя эффективность хирургического лечения является статистически значимо более высокой, применение объемообразующих средств связано с более низкой частотой осложнений. Эффективность пери-и трансуретральных инъекций сохраняется около года. Для поддержания эффекта удержания мочи требуются повторные инъекции.

ContigenCoaptiteUryxstress urinary incontinencevolume-forming agentsurodexbulkamidContigenCoaptiteUryxстрессовое недержание мочиобъемообразующие средствауродексбулкамидАполихина И.А. Клиническая эпидемиология, дифференциальная диагностика и консервативное лечение недержания мочи у женщин: Автореф. дис.. д-ра мед. наук. -М., 2006.Abrams P., Cardozo L., Fall M. et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society // Urology. - 2003. - Vol. 61. -P. 37-49.Abrams P., Cardozo L. et al. Bulking agents - injectables // Incontinence. - 4-th Ed. - London: Springer-Verlag. -2009. - P. 571-572.Appell R., Roger D., Robert M. et al. Clinical experience with coaptite (tm) urological bulking agent // Proceedings of the International Continence Society: 33-rd Annual meeting. - 2003. - P. 350-351.Bano F., Barrington J.W., Dyer R. Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence // Int. Urogynecol. J. - 2005. - Vol. 16. - P. 147-150.Bezerra C.A., Bruschini H., Cody D.J. Nraditional suburethral sling operations for urinary incontinence in women // Cochrane Database syst. Rev. - 2005. - № 3. - CD001754.Chaliha C., Williams G. Periurethral injection therapy for the treatment of urinary incontinence // Br. J. Urol. - 1995. -Vol. 76. - P. 151-156.Chapple C., Haab F., Cervigni M. An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence // Eur. Urol. - 2005. - Vol. 48. - P. 488-494.Corcos J., Collet J.P., Shapiro S. et al. Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence // Urology. -2005. - Vol. 65. - P. 898-904.Corcos J., Collet J.P., Shapiro S. et al. Surgery vs collagen for the treatment of female stress urinary incontinence (SUI): results of a multicentric randomized trial // J. Urol. (Baltimore). - 2001. - Vol. 165, № 5 (suppl.). - P. 198.Dean N.M., Ellis G., Wilson P.D. et al. Laparoscopic colposuspension for urinary incontinence in women // Cochrane Database Syst. Rev. - 2006. - № 3. - CD 002239.Dmochowski R., Appell R., Klimberg I. et. al. Initial clinical results from coaptite injection for stress urinary incontinence comparative clinical study // Proceedings of the International Continence Society (ICS): 32nd Annual meeting. - Heidelberg, 2002. - P. 184-185.Dmochowski R., Herschorn S., Corcos J. et al. Multicenter randomized controlled study to evaluate uryx urethral bulking agent in treating female stress urinary incontinence // Proceedings of the International Continence Society (ICS): 32nd Annual meeting. - Heidelberg, 2002. - P. 187.Dmochowski R., Herschorn S., Karram M. et al. Multicenter randomized controlled trial to evaluate URYX urethral bulking agent in treating female stress urinary incontinence: comparison of initial and expansion phases of trial // Int. Urogynecol. Ass. - 2004. - P. 657.Dmochowski R., Herschorn S., Corcos J. et al. Multicenter randomized controlled study to evaluate URYX© urethral bulking agent in treating female stress urinary incontinence // Proceedings of the International Continence Society: 33rd Annual meeting. - 2003. - P. 263.Dugan E., Cohen S., Bland D.R. et al. The association of depressive symptoms and urinary incontinence among older adults // J. Am. Geriatr. Soc. - 2000. - Vol. 48. - P. 413-416.Hannestad Y.S., Rortveit G., Sandik H. et al. Epidemiology of Incontinence in the County of Nord-Trondelag // J. Clin. Epidemiol. - 2000. - Vol.53. - P. 1150 -1157.Keegan P.E., Atiemo K., Cody J.D. et al. Periurethral injection therapy for urinary incontinence in women // Cochrane Database Syst. Rev. - 2007. - № 3. - CD003881.Lightner D., Calvosa C., Andersen R. et al. A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere // Urology. -2001. - Vol. 58. - P. 12-15.Lose G., Fynes M., Tegerstedt G. et al. Durability of polyacrylamide hydrogel (Bulkamid) injection for female stress and mixed urinary incontinence: 2-year multicenter study results // ICS // IUGA. - 2010. - P. 225.Maher C.F., Dwyer P.L., Carey M.P. et al. Pubovaginal sling or transurethral macroplastique for genuine stress incontinence and intrinsic sphincter deficiency: a prospective randomized trial // Int. Urogynecol. J. - 2001. - Vol. 12. - P. 9.Maher C.F., O’Reilly B.A., Dwyer P.L. et al. Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial // Br. J. Obstet. Gynaecol. - 2005. - Vol. 112. - P. 797-801.Melville J.L., Walker E., Katon W. et al. Prevalence of comorbid psychiatric illness and its impact on symptom perception, quality of life, and functional status in women with urinary incontinence // Am J. Obstet. Gynecol. - 2002. - Vol. 187. - P. 80-87.Renganathan A., Errichiello L., Robinson D. et al. Redefining the success rate of bulking agents: role of composite endpoints // Am J. Obstet. Gynecol. - 2007. - Vol. 197. - P. 647.Viktrup L., Koke S., Burgio K.L. et al. Stress urinary incontinence in active elderly women // South. Med. J. - 2005. - Vol. 98. -P. 79-89.Zamechnik L., Hanus T., Dvoracek J. A first trial of dx // hyaluronic acidi (Urodex) for the local treatment of stress urinary incontinence // 2007. P. 37-38.